E261 Peritoneal Recurrence a Potential Surrogate Endpoint for Overall Survival in Cytoreductive Surgery/ Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Clinical Trials

ANNALS OF SURGICAL ONCOLOGY(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要